1985
DOI: 10.1016/0005-2736(85)90451-1
|View full text |Cite
|
Sign up to set email alerts
|

Action of phospholipase A2 on bilayers. Effect of inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
37
0

Year Published

1987
1987
1999
1999

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 70 publications
(39 citation statements)
references
References 17 publications
2
37
0
Order By: Relevance
“…Mepacrine inhibits the PLA 2 activity by interfering with substrate binding in the active site of the enzyme [16]. This is a noncovalent interaction and should, thus, be significantly reversed when the agent is removed from the cells by several washing steps.…”
Section: Effects Of Pla 2 Inhibition By Mepacrine On Nk Cell Cytotoximentioning
confidence: 99%
See 1 more Smart Citation
“…Mepacrine inhibits the PLA 2 activity by interfering with substrate binding in the active site of the enzyme [16]. This is a noncovalent interaction and should, thus, be significantly reversed when the agent is removed from the cells by several washing steps.…”
Section: Effects Of Pla 2 Inhibition By Mepacrine On Nk Cell Cytotoximentioning
confidence: 99%
“…However, the PLA 2 inhibitors used in these studies, mepacrine [16] and 4-bromophenacyl bromide (BPB) [17], can also inhibit PLC [18,19] and may potentially inhibit NK cytotoxicity by virtue of inhibiting PLC. Thus, it is necessary, initially, to determine the minimum effective concentration of these agents and to ascertain their effects on the activation of NK PLC in response to target cell stimulation.…”
Section: Introductionmentioning
confidence: 99%
“…The modes of the indirect actions of G-Rbl and GLR can be compared with those of PLA2 and calmodulin inhibitors as described in the previous paper . The mode by which G-Rbl inhibits the effect of PLA2 is similar to those of quinacrine, a nonspecific inhibitor of the enzyme (Jain and Jahagirdar, 1985), and cortisone, which might accelerate the production of lipocortins (Hirata et al, 1980). In contrast, the mode of action of GLR is similar to that of tetracaine, an inhibitor of calmodulin (Volpi ef al., 1981).…”
Section: Discussionmentioning
confidence: 90%
“…Furthermore, as p-bromophenacylbromide specifically binds to the histidine residue in the active site of phospholipase A2 (Volwerck et af. 1974) The inhibitory effect of quinacrine on adrenaline-stimulated incorporation of linoleic acid into phospholipid can be considered a specific effect on phospholipase A2 activity because kinetic studies, performed on model bilayer membranes, with quinacrine (Jain and Jahagudar 1985) have shown that the substrate interface is altered by the inhibitor, which prevents the phospholipase A2 from binding with its substrate. Thus quinacrine interacts with phosphatidylcholine and phosphatidylethanolamine and shields these lipids, whereas other phospholipids such as phosphatidylserine and phosphatidylinositol are not affected and may still be hydrolysed by phospholipase A 2 • The adipocyte ghost contains 32.5070 phosphatidylcholine, 24% phosphatidylethanolamine and 17.9% phosphatidylserine and phosphatidylinositol combined.…”
Section: Discussionmentioning
confidence: 99%